认识我们尊敬的演讲嘉宾和嘉宾讲者

所有发言者都必须遵循 IMCAS 利益冲突政策 ,以确保该日程的科学透明度和独立性。

演讲者名单由我们的科学秘书处不断更新。请定期回来查看最新动态。

讲者欢迎词

Steven R COHEN 医师 avatar

Steven R COHEN 医师

整形外科医师, 美国

“Please join me at IMCAS Paris, the world’s premier aesthetic education. The venue this year promises to be among the best ever with incredible faculty from all over the world. As one of the board members for surgery, I invite you to enjoy the new friendships you will make and the wonderful exchange of new ideas! See you in Paris!”

Javier BEUT 医师 avatar

Javier BEUT 医师

美容整型外科医师, 西班牙

“For more than 20 years, I’ve had the privilege of participating as a scientific speaker at IMCAS. This unique congress brings together a blend of specialties, creating a melting pot of knowledge, innovation, and camaraderie. It’s a meeting like no other—where colleagues from around the globe exchange insights, share experiences, and forge lasting friendships.I look forward to welcoming you all to IMCAS Paris 2025—a space where science meets friendship and innovation inspires the future! ”

Jennifer L WALDEN 医师 avatar

Jennifer L WALDEN 医师

整形外科医师, 美国

“So excited to return as an invited speaker to IMCAS in Paris! I will be talking about rapid facial volume loss and and how to address these changes with surgical / non surgical facial rejuvenation. Also labiaplasty and sexual wellness topics! See you there! ”

Roxanna SADOUGHIFAR Prof avatar

Roxanna SADOUGHIFAR Prof

医学博士, 伊朗

“Dear colleagues, It is with great pleasure that I welcome you all to the vibrant and historic city of Paris for IMCAS 2025. This prestigious congress promises to be a valuable opportunity for us to share knowledge, exchange ideas, and stay at the forefront of advancements in our field. Paris, with its timeless charm and rich culture, serves as the perfect backdrop for this gathering of brilliant minds. I encourage you to make the most of this unique occasion by attending Imcas 2025 !”

Barry DEKEYSER 医师 avatar

Barry DEKEYSER 医师

麻醉师, 比利时

“In my presentation, I will provide physicians with a systematic approach to diagnosing and treating common hair disorders, based on my extensive experience as a practitioner, trainer, and advisor in hair conditions. The role of trichoscopy in diagnostics will be highlighted. Several case studies will be presented, where patients were treated with platelet-rich plasma (PRP) and/or Er:YAG laser therapy. PRP and LASER are two modalities that have garnered significant interest.”

Ana BENDITO 医师 avatar

Ana BENDITO 医师

医学博士, 瑞典

“Dear Colleagues, I’m excited to announce that I will be speaking on February 1 about: “Non-Surgical Eyebrow Reshaping Using Combined Methods” — featuring barbed threads, botulinum toxin, and HA fillers. I look forward to seeing you all there!”

Steven BENGELSDORF 医师 avatar

Steven BENGELSDORF 医师

美容整型外科医师, 美国

“I am so excited to be on the invited faculty of IMCAS this year. IMCAS is THE global conference to attend for anyone interested in high level information on cosmetic dermatology, cosmetic surgery, and anti-aging. Being able to collaborate with peers from the global stage provides opportunities not available at national conferences in the United States. If you are only able to attend one conference this year, this is the one to go to. ”

Patricia APT DRUCK 医师 avatar

Patricia APT DRUCK 医师

皮肤科医师, 智利

“Dear colleagues, It is my honor to invite you to attend my sessions during the Congress in Paris, where we will delve into the latest advancements in laser technology for facial rejuvenation and effective melasma management. In these talks, I will share my clinical experiences, and the latest technological innovations that are transforming outcomes in aesthetic . Laser skin rejuvenation Thursday 30 Jan 2025 14:30-15:30 How to deal with Melasma Saturday 1 Feb 2025 10:30-12:30”

Rachita DHURAT 医师 avatar

Rachita DHURAT 医师

皮肤科医师, 印度

“Cetirizine has demonstrated inhibitory effects on prostaglandin D2 synthesis, a molecule implicated in the pathogenesis of hair follicle miniaturization in AGA. In our case series there was an increase in the hair count as compared to the baseline in 9/9 subjects post 16 weeks of therapy. The mean hair count at week 0 was 139.56 (SE of mean of 13.92) and at 16 weeks was 163.44 (SE of mean of 15.52). Cetirizine presents a potential addition to the therapeutic armamentarium for AGA.”

发现 IMCAS Academy

关注 IMCAS

需要帮助吗?

隐私政策 法律信息
© 2026 IMCAS - 国际医学美容抗衰老大师课程 版权所有。
处理中,请稍候...

错误

请填写所有必填字段。以下是缺失的字段: